- Home
- BDTX vs CBUS Comparison
BDTX vs CBUS Comparison
Compare BDTX & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDTX | CBUS |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 121.1M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BDTX | CBUS |
|---|---|---|
| Price | $2.60 | $1.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $9.67 | $9.00 |
| AVG Volume (30 Days) | ★ 802.4K | 617.1K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 130.71 | 74.33 |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | ★ $3,639,000.00 |
| Revenue This Year | N/A | $112.72 |
| Revenue Next Year | N/A | $83.18 |
| P/E Ratio | $6.83 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.46 | $1.09 |
| 52 Week High | $4.94 | $4.19 |
Technical Indicators
Market Signals| Indicator | BDTX | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 39.95 |
| Support Level | $2.45 | $1.43 |
| Resistance Level | $2.79 | $1.50 |
| Average True Range (ATR) | 0.20 | 0.11 |
| MACD | -0.06 | 0.05 |
| Stochastic Oscillator | 7.26 | 52.94 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.